Essex Small/Micro Cap Growth Fund  (MBRSX)

Fund Overview

Fund Overview

Share Class

N

Morningstar | Style Box

V B G L M S

NAV | as of 03/22/2019

$21.74
-$0.89 (-3.93%)

Quarterly Performance (%) |
vs. Benchmark as of 12/31/2018

Fund Inception 09/28/2000

YTD 1YR 3YR 5YR 10YR INCEP.
MBRSX -6.26 -6.26 7.99 4.14 12.90 9.04
Russell 2000® Growth Index -9.31 -9.31 7.24 5.13 13.52 4.79
View Monthly & Quarterly Performance Details

The performance data shown represents past performance. Past performance is not a guarantee of future results. Current performance may be lower or higher than the performance quoted. The investment return and the principal value of an investment will fluctuate so that an investor’s shares, when redeemed, may be worth more or less than their original cost. For performance information through the most recent month end please call 800.835.3879 or visit our website at amgfunds.com. From time to time, the advisor has waived fees or reimbursed expenses, which may have resulted in higher returns. The listed returns and yields of the Fund are net of expenses, and the returns and yields of the indices exclude expenses.

Expense Ratios

  • Gross Expense Ratio: 1.62%
  • Net Expense Ratio: 1.49%
  • Expense Cap Expiration Date: 10/01/2019

Read Important Investment Disclosures

Objective

The Fund seeks to achieve long-term capital appreciation by investing primarily in small and micro cap securities.

Why Consider

  • May be suitable for investors seeking exposure to a high conviction portfolio of small to micro cap companies with changing growth prospects reflected by earnings and revenue acceleration
  • The portfolio is constructed with companies transitioning through different phases of growth, exhibiting a diverse range of growth characteristics and industries, across market sectors
  • Allocates to sectors based on fundamental analysis rather than benchmark constraints while relying on fundamental research for security selection

Fund Managers

Nancy Prial, CFA

Co-Chief Executive Officer of Essex & Portfolio Manager

Read Full Bio

Performance

Performance

Read Important Investment Disclosures

Returns & Distributions

As of 12/31/2018

    • Ex-Date Total Distribution Income Short-term Cap Gains Long-term Cap Gains
      Dec 27, 2018 $6.030400 $6.030400
      Dec 27, 2017 $3.005200 $3.005200
      Dec 27, 2016 $0.986500 $0.986500
      Dec 28, 2015 $2.523300 $2.523300
      Dec 26, 2014 $2.333300 $2.333300
      Dec 26, 2013 $3.262400 $0.962700 $2.299700
      Dec 26, 2007 $0.236300 $0.236300
      Dec 26, 2006 $0.094000 $0.094000
      Dec 27, 2005 $0.764000 $0.764000
      Dec 28, 2004 $0.595000 $0.489000 $0.106000
      Dec 26, 2003 $0.160000 $0.100000 $0.060000

Growth of $10,000 (Hypothetical)

Since Inception 09/28/2000 to 02/28/2019 = $58,478.09

  • 3YR
  • 5YR
  • 10YR
  • INCEP.
INCEP.
  • 3YR
  • 5YR
  • 10YR
  • INCEP.

The performance data shown represents past performance. Past performance is not a guarantee of future results. Current performance may be lower or higher than the performance data quoted. The investment return and the principal value of an investment will fluctuate so that an investor's shares, when redeemed, may be worth more or less than their original cost. For performance information through the most recent month end please call 800.835.3879 or visit our website at amgfunds.com. From time to time, the advisor has waived fees or reimbursed expenses, which may have resulted in higher returns. The listed returns and yields of the Fund are net of expenses, and the returns and yields of the indices exclude expenses. For time periods where the fund inception date preceded the benchmark, the benchmark data will not be shown.

Top Holdings (Equity)

As of: 12/31/2018

Novanta Inc 2.70%
Five Below Inc 2.16%
Veracyte Inc 2.08%
Attunity Ltd 2.03%
Novocure Ltd 1.98%
Chegg Inc 1.98%
Mitek Systems Inc 1.97%
Insulet Corp 1.91%
Nuvectra Corp 1.68%
BioLife Solutions Inc 1.62%
% in Top 10 Holdings 20.11%
View Holding Details Read Important Investment Disclosures

MPT Stats

As of: 02/28/2019

View All Characteristics & Stats

Sector Allocation (Equity)

As of: 12/31/2018

Investment Approach

Investment Approach

Essex Small/Micro Cap Growth Fund

Essex believes a company’s price performance is driven by its revenue growth, future profitability and cash flow. The AMG Managers Essex Small/Micro Cap Growth Fund focuses on recognizing an earnings rebound or improvement before the market is able to reflect the improvement in a stock’s price. The Fund focuses on the small cap universe, specifically companies with $50 million to $1.5 billion in market capitalization.

Additional Fund Highlight

Sector weighting is dependent on fundamental analysis rather than benchmark constraints.

Keep Calm and Remain Diversified

 
A short- and long-term review of the power of diversification.
Read Full Perspective

About

About Essex Investment Management

Background

Essex Investment Management manages growth equity portfolios for institutional clients, high net worth clients, mutual funds and private partnerships based on early identification of growth, wherever it exists.

Learn More

Founded

1976


Headquarters

Boston, MA


AUM

$0.6B

Funds to Consider

MGFIX

Loomis Sayles Bond Fund

Seeks a high level of current income by investing in a flexible portfolio of fixed income securities.


Overall Morningstar Rating

Rated against 879 Intermediate-Term Bond funds as of 02/28/2019
★★★★★

MGFIX
Bloomberg Barclays U.S. Government/Credit Bond Index

Quarterly performance (%) data as of 12/31/2018

Fund Detail Read Important Investment Disclosures

TCMPX

TimesSquare International Small Cap Fund

Seeks to provide long-term capital appreciation by primarily investing in international small cap companies.


Overall Morningstar Rating

Rated against 118 Foreign Small/Mid Growth funds as of 02/28/2019
★★★

TCMPX
MSCI EAFE Small Cap Index

Quarterly performance (%) data as of 12/31/2018

Fund Detail Read Important Investment Disclosures

HLMNX

Harding Loevner International Equity Portfolio

The Portfolio seeks long-term capital appreciation through investments in equity securities of companies based outside the United States.


Overall Morningstar Rating

Rated against 366 Foreign Large Growth funds as of 02/28/2019
★★★★

HLMNX
MSCI ACWI ex USA Index

Quarterly performance (%) data as of 12/31/2018

Fund Detail Read Important Investment Disclosures

Discover how AMG Funds brings more than 100 products from over 30 independent boutiques together under one flag.

Learn More About AMG Funds
  Back To Top